반응식
[C:1]1([N:7]2[C:19](=[O:20])[C:10]3=[CH:11][NH:12][C:13]4[CH:14]=[CH:15][CH:16]=[CH:17][C:18]=4[C:9]3=[N:8]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.ClC1C2C(=CC=C([C:32]([F:35])([F:34])[F:33])C=2)N=CC=1C(OCC)=O.C1(NN)C=CC=CC=1>>[C:1]1([N:7]2[C:19](=[O:20])[C:10]3=[CH:11][NH:12][C:13]4[CH:14]=[CH:15][C:16]([C:32]([F:35])([F:34])[F:33])=[CH:17][C:18]=4[C:9]3=[N:8]2)[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1참가 물질
4
실험 절차
The title compound was prepared following the procedure described in Step 3 of the synthesis of 4a, using 3h and phenyl hydrazine. 1H NMR (DMSO-d6) δ (ppm): 7.21 (1H, m), 7.42 (2H, t, J=7.56 Hz), 7.97 (1H, d, J=2.20 Hz), 8.00 (1H, d, J=2.20 Hz), 8.20 (1H, ddd, J=7.41, 1.10, 0.83 Hz), 8.43 (2H, dd, J=1.33, 0.83 Hz), 8.82 (1H, s). m/z 330.2 (MH+).
출처 및 근거
- ORD 기록
- ord-d48eb93e24c84e78a3c09da6918825f2
- 출처 데이터셋
- uspto-grants-2011_01
- 특허 번호
- US07863266B2
연결된 노트
불러오는 중…